Sight Sciences, Inc.
- Last sale
- Oct 19, 2026 · -0.36%
- Market cap
- $456.39M
- 55.22M shares
- Filings
- 509
Q3 2026−3.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−23.6% FY25 yoy
- $456.39M
- —
- 5.2×
- 9.3×
- -3.71%
- —
Twelve months to Sep 30, 2026 · derived
Price
Oct 19, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $77,363,000 | reported | |
| FY 2024 | 2024-12-31 | $79,866,000 | reported | |
| FY 2023 | 2023-12-31 | $81,056,000 | reported | |
| FY 2022 | 2022-12-31 | $71,331,000 | reported | |
| FY 2021 | 2021-12-31 | $48,956,000 | reported | |
| FY 2020 | 2020-12-31 | $27,640,000 | reported |
Segments
Segments
LineFY2025ShareChange
Interventional Glaucoma$75.72M98%−0.2%
Interventional Dry Eye$1.64M2.1%−58.7%
Total$77.36M
Surgical & medical instruments & apparatus
Sight Sciences, Inc. is the 57th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
KMTSKestra Medical Technologies, Ltd.$95.1M59.0%138.4%$1.7BLUNGPulmonx Corp$90.5M8.0%59.7%$130.9MDCTHDelcath Systems, Inc.$85.2M129.1%3.2%$743.1MIRMDIradimed Corp$83.8M14.4%26.8%$1.1BTELATELA Bio, Inc.$80.3M15.8%48.4%$38.0MPDEXPro DEX Inc$77.5M16.5%17.6%$225.5M
SGHTSight Sciences, Inc. (this company)$77.4M3.1%49.7%$456.4M
RCELAVITA Medical, Inc.$71.6M11.5%67.8%$507.1MMHUAFMeihua International Medical Technologies Co., Ltd.$61.8M36.2%11.0%$6.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Sight Sciences, Inc. · CIK 1531177 · Engraved from SEC EDGAR